Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 3 of 3 for “"glucose-lowering agent"”.

  1. Investigation of potential intervention targets to improve insulin action: a therapeutic approach

    … the mechanism of action of pharmacological agents and exogenous peptides known or suspected to modify insulin action. These included leptin, a hormone primarily involved in the regulation of body weight; sibutramine, an antiobesity agent; plant-derived compounds (pinitol and chamaemeloside) …

    aston Repository record for Investigation of potential intervention targets to improve insulin action: a therapeutic approach (opens in a new tab)

  2. THE ROLE OF HYPOGLYCEMIC AGENTS IN AMELIORATING COGNITIVE FUNCTIONS AND PSYCHIATRIC SYMPTOMS: FROM THE PSYCHIATRIC PATIENT TO EVIDENCE-BASED AND PHARMACOEPIDEMIOLOGIC APPROACHES FOR SUPPORTING THE CLINICAL PRACTICE

    Background: Research highlights a complex link between diabetes-related factors such as insulin resistance, hyperglycemia, and chronic inflammation, all contributing to cognitive decline. Schizophrenia and depression, which often co-occur with type 2 diabetes mellitus, show a bidirectional …

    milano Repository record for THE ROLE OF HYPOGLYCEMIC AGENTS IN AMELIORATING COGNITIVE FUNCTIONS AND PSYCHIATRIC SYMPTOMS: FROM THE PSYCHIATRIC PATIENT TO EVIDENCE-BASED AND PHARMACOEPIDEMIOLOGIC APPROACHES FOR SUPPORTING THE CLINICAL PRACTICE (opens in a new tab)

  3. The effect of maternal obesity/GDM and metformin intervention on maternal, placental and fetal health

    … Overall, it is well-established that obese and glucose-intolerant pregnancies have short- and long-term health consequences for mother and child. Women with GDM are therefore treated to control maternal glycaemia and thereby prevent effects on the fetus caused by excessive glucose exposure. In …

    cambridge Repository record for The effect of maternal obesity/GDM and metformin intervention on maternal, placental and fetal health (opens in a new tab)